Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

January 01, 1995; Volume 23,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anders, M W

    1. You have access
      Metabolism of [14C]- and [35S]S-(1,2-dichlorovinyl)-L-cysteine in the male Fischer 344 rat.
      M B Finkelstein, N J Patel and M W Anders
      Drug Metabolism and Disposition January 1995, 23 (1) 124-128;
    2. You have access
      Biosynthesis of S-(2-chloro-1,1,2-trifluoroethyl)glutathione in rat and human hepatocytes and in Hep G2 cells.
      E Tanaka and M W Anders
      Drug Metabolism and Disposition January 1995, 23 (1) 48-54;
  2. Andersson, P

    1. You have access
      Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.
      G Jönsson, A Aström and P Andersson
      Drug Metabolism and Disposition January 1995, 23 (1) 137-142;
  3. Aström, A

    1. You have access
      Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.
      G Jönsson, A Aström and P Andersson
      Drug Metabolism and Disposition January 1995, 23 (1) 137-142;

B

  1. Baker, M T

    1. You have access
      Isoflurane-chlorodifluoroethene interaction in human liver microsomes. Role of cytochrome P4502B6 in potentiation of haloethene metabolism.
      M T Baker, M J Olson, Y Wang, W C Ronnenberg, J T Johnson and A N Brady
      Drug Metabolism and Disposition January 1995, 23 (1) 60-64;
  2. Benfenati, E

    1. You have access
      Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
      A Magistrelli, P Villa, E Benfenati, E J Modest, M Salmona and M T Tacconi
      Drug Metabolism and Disposition January 1995, 23 (1) 113-118;
  3. Blanz, J

    1. You have access
      Biotransformation of CI-937 in primary cultures of rat hepatocytes. Formation of glutathione conjugates.
      U Renner, J Blanz, S Freund, D Waidelich, G Ehninger and K P Zeller
      Drug Metabolism and Disposition January 1995, 23 (1) 94-101;
  4. Boado, R J

    1. You have access
      Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate.
      Y S Kang, R J Boado and W M Pardridge
      Drug Metabolism and Disposition January 1995, 23 (1) 55-59;
  5. Brady, A N

    1. You have access
      Isoflurane-chlorodifluoroethene interaction in human liver microsomes. Role of cytochrome P4502B6 in potentiation of haloethene metabolism.
      M T Baker, M J Olson, Y Wang, W C Ronnenberg, J T Johnson and A N Brady
      Drug Metabolism and Disposition January 1995, 23 (1) 60-64;
  6. Brewer, T G

    1. You have access
      Side-chain hydroxylation in the metabolism of 8-aminoquinoline antiparasitic agents.
      O R Idowu, J O Peggins and T G Brewer
      Drug Metabolism and Disposition January 1995, 23 (1) 18-27;
    2. You have access
      Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes.
      O R Idowu, J O Peggins, T G Brewer and C Kelley
      Drug Metabolism and Disposition January 1995, 23 (1) 1-17;

C

  1. Chauret, N

    1. You have access
      In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
      N Chauret, C Li, Y Ducharme, L A Trimble, J A Yergey, C Ramachandran and D A Nicoll-Griffith
      Drug Metabolism and Disposition January 1995, 23 (1) 65-71;
  2. Chikai, T

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  3. Collins, M A

    1. You have access
      Identification and quantification of fluorine-containing metabolites of 1-chloro-2,2,2-trifluoroethane (HCFC133A) in the rat by 19F-NMR spectroscopy.
      M K Ellis, J L Naylor, T Green and M A Collins
      Drug Metabolism and Disposition January 1995, 23 (1) 102-106;
  4. Creech Kraft, J

    1. You have access
      Xenopus laevis: a model system for the study of embryonic retinoid metabolism. II. Embryonic metabolism of all-trans-3,4-didehydroretinol to all-trans-3,4-didehydroretinoic acid.
      J Creech Kraft, D Kimelman and M R Juchau
      Drug Metabolism and Disposition January 1995, 23 (1) 83-89;

D

  1. Dickinson, R G

    1. You have access
      Characterization and formation of the glutathione conjugate of clofibric acid.
      L J Shore, C Fenselau, A R King and R G Dickinson
      Drug Metabolism and Disposition January 1995, 23 (1) 119-123;
  2. Ducharme, Y

    1. You have access
      In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
      N Chauret, C Li, Y Ducharme, L A Trimble, J A Yergey, C Ramachandran and D A Nicoll-Griffith
      Drug Metabolism and Disposition January 1995, 23 (1) 65-71;

E

  1. Ehninger, G

    1. You have access
      Biotransformation of CI-937 in primary cultures of rat hepatocytes. Formation of glutathione conjugates.
      U Renner, J Blanz, S Freund, D Waidelich, G Ehninger and K P Zeller
      Drug Metabolism and Disposition January 1995, 23 (1) 94-101;
  2. Ellis, M K

    1. You have access
      Identification and quantification of fluorine-containing metabolites of 1-chloro-2,2,2-trifluoroethane (HCFC133A) in the rat by 19F-NMR spectroscopy.
      M K Ellis, J L Naylor, T Green and M A Collins
      Drug Metabolism and Disposition January 1995, 23 (1) 102-106;

F

  1. Fenselau, C

    1. You have access
      Characterization and formation of the glutathione conjugate of clofibric acid.
      L J Shore, C Fenselau, A R King and R G Dickinson
      Drug Metabolism and Disposition January 1995, 23 (1) 119-123;
  2. Finkelstein, M B

    1. You have access
      Metabolism of [14C]- and [35S]S-(1,2-dichlorovinyl)-L-cysteine in the male Fischer 344 rat.
      M B Finkelstein, N J Patel and M W Anders
      Drug Metabolism and Disposition January 1995, 23 (1) 124-128;
  3. Freund, S

    1. You have access
      Biotransformation of CI-937 in primary cultures of rat hepatocytes. Formation of glutathione conjugates.
      U Renner, J Blanz, S Freund, D Waidelich, G Ehninger and K P Zeller
      Drug Metabolism and Disposition January 1995, 23 (1) 94-101;
  4. Fujii, Y

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  5. Fujikawa, A

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  6. Fujitsu, T

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;

G

  1. Gerstenberg, B

    1. You have access
      Nicotine and cotinine accumulation in pigmented and unpigmented rat hair.
      B Gerstenberg, G Schepers, P Voncken and H Völkel
      Drug Metabolism and Disposition January 1995, 23 (1) 143-148;
  2. Green, T

    1. You have access
      Identification and quantification of fluorine-containing metabolites of 1-chloro-2,2,2-trifluoroethane (HCFC133A) in the rat by 19F-NMR spectroscopy.
      M K Ellis, J L Naylor, T Green and M A Collins
      Drug Metabolism and Disposition January 1995, 23 (1) 102-106;

H

  1. Hamaguchi, T

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  2. Harvison, P J

    1. You have access
      Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide by isolated rat hepatocytes.
      A K Nyarko and P J Harvison
      Drug Metabolism and Disposition January 1995, 23 (1) 107-112;
  3. Hata, T

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  4. Higaki, K

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  5. Holland, M L

    1. You have access
      Pharmacokinetics and bioavailability of topiramate in the beagle dog.
      A J Streeter, P L Stahle, M L Holland, J F Pritchard and A R Takacs
      Drug Metabolism and Disposition January 1995, 23 (1) 90-93;

I

  1. Idowu, O R

    1. You have access
      Side-chain hydroxylation in the metabolism of 8-aminoquinoline antiparasitic agents.
      O R Idowu, J O Peggins and T G Brewer
      Drug Metabolism and Disposition January 1995, 23 (1) 18-27;
    2. You have access
      Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes.
      O R Idowu, J O Peggins, T G Brewer and C Kelley
      Drug Metabolism and Disposition January 1995, 23 (1) 1-17;
  2. Inazawa, K

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  3. Iwasaki, K

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;

J

  1. Johnson, J T

    1. You have access
      Isoflurane-chlorodifluoroethene interaction in human liver microsomes. Role of cytochrome P4502B6 in potentiation of haloethene metabolism.
      M T Baker, M J Olson, Y Wang, W C Ronnenberg, J T Johnson and A N Brady
      Drug Metabolism and Disposition January 1995, 23 (1) 60-64;
  2. Jones, A D

    1. You have access
      Metabolism of [14C]naphthalene in the B6C3F1 murine isolated perfused liver.
      L S Tsuruda, M W Lamé and A D Jones
      Drug Metabolism and Disposition January 1995, 23 (1) 129-136;
  3. Jönsson, G

    1. You have access
      Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.
      G Jönsson, A Aström and P Andersson
      Drug Metabolism and Disposition January 1995, 23 (1) 137-142;
  4. Juchau, M R

    1. You have access
      Xenopus laevis: a model system for the study of embryonic retinoid metabolism. I. Embryonic metabolism of 9-cis- and all-trans-retinals and retinols to their corresponding acid forms.
      J C Kraft, D Kimelman and M R Juchau
      Drug Metabolism and Disposition January 1995, 23 (1) 72-82;
    2. You have access
      Xenopus laevis: a model system for the study of embryonic retinoid metabolism. II. Embryonic metabolism of all-trans-3,4-didehydroretinol to all-trans-3,4-didehydroretinoic acid.
      J Creech Kraft, D Kimelman and M R Juchau
      Drug Metabolism and Disposition January 1995, 23 (1) 83-89;

K

  1. Kadono, K

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  2. Kamata, K

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  3. Kang, Y S

    1. You have access
      Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate.
      Y S Kang, R J Boado and W M Pardridge
      Drug Metabolism and Disposition January 1995, 23 (1) 55-59;
  4. Kawahara, S

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  5. Kelley, C

    1. You have access
      Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes.
      O R Idowu, J O Peggins, T G Brewer and C Kelley
      Drug Metabolism and Disposition January 1995, 23 (1) 1-17;
  6. Kimelman, D

    1. You have access
      Xenopus laevis: a model system for the study of embryonic retinoid metabolism. I. Embryonic metabolism of 9-cis- and all-trans-retinals and retinols to their corresponding acid forms.
      J C Kraft, D Kimelman and M R Juchau
      Drug Metabolism and Disposition January 1995, 23 (1) 72-82;
    2. You have access
      Xenopus laevis: a model system for the study of embryonic retinoid metabolism. II. Embryonic metabolism of all-trans-3,4-didehydroretinol to all-trans-3,4-didehydroretinoic acid.
      J Creech Kraft, D Kimelman and M R Juchau
      Drug Metabolism and Disposition January 1995, 23 (1) 83-89;
  7. King, A R

    1. You have access
      Characterization and formation of the glutathione conjugate of clofibric acid.
      L J Shore, C Fenselau, A R King and R G Dickinson
      Drug Metabolism and Disposition January 1995, 23 (1) 119-123;
  8. Kraft, J C

    1. You have access
      Xenopus laevis: a model system for the study of embryonic retinoid metabolism. I. Embryonic metabolism of 9-cis- and all-trans-retinals and retinols to their corresponding acid forms.
      J C Kraft, D Kimelman and M R Juchau
      Drug Metabolism and Disposition January 1995, 23 (1) 72-82;

L

  1. Lamé, M W

    1. You have access
      Metabolism of [14C]naphthalene in the B6C3F1 murine isolated perfused liver.
      L S Tsuruda, M W Lamé and A D Jones
      Drug Metabolism and Disposition January 1995, 23 (1) 129-136;
  2. Li, C

    1. You have access
      In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
      N Chauret, C Li, Y Ducharme, L A Trimble, J A Yergey, C Ramachandran and D A Nicoll-Griffith
      Drug Metabolism and Disposition January 1995, 23 (1) 65-71;
  3. Lu, A Y

    1. You have access
      Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
      D J Newton, R W Wang and A Y Lu
      Drug Metabolism and Disposition January 1995, 23 (1) 154-158;

M

  1. Magistrelli, A

    1. You have access
      Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
      A Magistrelli, P Villa, E Benfenati, E J Modest, M Salmona and M T Tacconi
      Drug Metabolism and Disposition January 1995, 23 (1) 113-118;
  2. Matsuda, H

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  3. Modest, E J

    1. You have access
      Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
      A Magistrelli, P Villa, E Benfenati, E J Modest, M Salmona and M T Tacconi
      Drug Metabolism and Disposition January 1995, 23 (1) 113-118;
  4. Monshouwer, M

    1. You have access
      Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.
      M Monshouwer, R F Witkamp, S M Nijmeijer, L A Van Leengoed, J H Verheijden and A S Van Miert
      Drug Metabolism and Disposition January 1995, 23 (1) 44-47;

N

  1. Nagase, K

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  2. Nakano, M

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  3. Naylor, J L

    1. You have access
      Identification and quantification of fluorine-containing metabolites of 1-chloro-2,2,2-trifluoroethane (HCFC133A) in the rat by 19F-NMR spectroscopy.
      M K Ellis, J L Naylor, T Green and M A Collins
      Drug Metabolism and Disposition January 1995, 23 (1) 102-106;
  4. Nellans, H N

    1. You have access
      Stereoselective glucuronidation of zileuton isomers by human hepatic microsomes.
      D J Sweeny and H N Nellans
      Drug Metabolism and Disposition January 1995, 23 (1) 149-153;
  5. Newton, D J

    1. You have access
      Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
      D J Newton, R W Wang and A Y Lu
      Drug Metabolism and Disposition January 1995, 23 (1) 154-158;
  6. Nicoll-Griffith, D A

    1. You have access
      In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
      N Chauret, C Li, Y Ducharme, L A Trimble, J A Yergey, C Ramachandran and D A Nicoll-Griffith
      Drug Metabolism and Disposition January 1995, 23 (1) 65-71;
  7. Nijmeijer, S M

    1. You have access
      Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.
      M Monshouwer, R F Witkamp, S M Nijmeijer, L A Van Leengoed, J H Verheijden and A S Van Miert
      Drug Metabolism and Disposition January 1995, 23 (1) 44-47;
  8. Nyarko, A K

    1. You have access
      Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide by isolated rat hepatocytes.
      A K Nyarko and P J Harvison
      Drug Metabolism and Disposition January 1995, 23 (1) 107-112;

O

  1. Olson, M J

    1. You have access
      Isoflurane-chlorodifluoroethene interaction in human liver microsomes. Role of cytochrome P4502B6 in potentiation of haloethene metabolism.
      M T Baker, M J Olson, Y Wang, W C Ronnenberg, J T Johnson and A N Brady
      Drug Metabolism and Disposition January 1995, 23 (1) 60-64;

P

  1. Pardridge, W M

    1. You have access
      Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate.
      Y S Kang, R J Boado and W M Pardridge
      Drug Metabolism and Disposition January 1995, 23 (1) 55-59;
  2. Patel, N J

    1. You have access
      Metabolism of [14C]- and [35S]S-(1,2-dichlorovinyl)-L-cysteine in the male Fischer 344 rat.
      M B Finkelstein, N J Patel and M W Anders
      Drug Metabolism and Disposition January 1995, 23 (1) 124-128;
  3. Peggins, J O

    1. You have access
      Side-chain hydroxylation in the metabolism of 8-aminoquinoline antiparasitic agents.
      O R Idowu, J O Peggins and T G Brewer
      Drug Metabolism and Disposition January 1995, 23 (1) 18-27;
    2. You have access
      Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes.
      O R Idowu, J O Peggins, T G Brewer and C Kelley
      Drug Metabolism and Disposition January 1995, 23 (1) 1-17;
  4. Pritchard, J F

    1. You have access
      Pharmacokinetics and bioavailability of topiramate in the beagle dog.
      A J Streeter, P L Stahle, M L Holland, J F Pritchard and A R Takacs
      Drug Metabolism and Disposition January 1995, 23 (1) 90-93;

R

  1. Ramachandran, C

    1. You have access
      In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
      N Chauret, C Li, Y Ducharme, L A Trimble, J A Yergey, C Ramachandran and D A Nicoll-Griffith
      Drug Metabolism and Disposition January 1995, 23 (1) 65-71;
  2. Renner, U

    1. You have access
      Biotransformation of CI-937 in primary cultures of rat hepatocytes. Formation of glutathione conjugates.
      U Renner, J Blanz, S Freund, D Waidelich, G Ehninger and K P Zeller
      Drug Metabolism and Disposition January 1995, 23 (1) 94-101;
  3. Ronnenberg, W C

    1. You have access
      Isoflurane-chlorodifluoroethene interaction in human liver microsomes. Role of cytochrome P4502B6 in potentiation of haloethene metabolism.
      M T Baker, M J Olson, Y Wang, W C Ronnenberg, J T Johnson and A N Brady
      Drug Metabolism and Disposition January 1995, 23 (1) 60-64;

S

  1. Sakuma, S

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  2. Salmona, M

    1. You have access
      Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
      A Magistrelli, P Villa, E Benfenati, E J Modest, M Salmona and M T Tacconi
      Drug Metabolism and Disposition January 1995, 23 (1) 113-118;
  3. Schepers, G

    1. You have access
      Nicotine and cotinine accumulation in pigmented and unpigmented rat hair.
      B Gerstenberg, G Schepers, P Voncken and H Völkel
      Drug Metabolism and Disposition January 1995, 23 (1) 143-148;
  4. Shiraga, T

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  5. Shore, L J

    1. You have access
      Characterization and formation of the glutathione conjugate of clofibric acid.
      L J Shore, C Fenselau, A R King and R G Dickinson
      Drug Metabolism and Disposition January 1995, 23 (1) 119-123;
  6. Stahle, P L

    1. You have access
      Pharmacokinetics and bioavailability of topiramate in the beagle dog.
      A J Streeter, P L Stahle, M L Holland, J F Pritchard and A R Takacs
      Drug Metabolism and Disposition January 1995, 23 (1) 90-93;
  7. Streeter, A J

    1. You have access
      Pharmacokinetics and bioavailability of topiramate in the beagle dog.
      A J Streeter, P L Stahle, M L Holland, J F Pritchard and A R Takacs
      Drug Metabolism and Disposition January 1995, 23 (1) 90-93;
  8. Sweeny, D J

    1. You have access
      Stereoselective glucuronidation of zileuton isomers by human hepatic microsomes.
      D J Sweeny and H N Nellans
      Drug Metabolism and Disposition January 1995, 23 (1) 149-153;

T

  1. Tacconi, M T

    1. You have access
      Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
      A Magistrelli, P Villa, E Benfenati, E J Modest, M Salmona and M T Tacconi
      Drug Metabolism and Disposition January 1995, 23 (1) 113-118;
  2. Takacs, A R

    1. You have access
      Pharmacokinetics and bioavailability of topiramate in the beagle dog.
      A J Streeter, P L Stahle, M L Holland, J F Pritchard and A R Takacs
      Drug Metabolism and Disposition January 1995, 23 (1) 90-93;
  3. Takeuchi, M

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  4. Tanaka, E

    1. You have access
      Biosynthesis of S-(2-chloro-1,1,2-trifluoroethyl)glutathione in rat and human hepatocytes and in Hep G2 cells.
      E Tanaka and M W Anders
      Drug Metabolism and Disposition January 1995, 23 (1) 48-54;
  5. Tokuma, Y

    1. You have access
      Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
      K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
      Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  6. Trimble, L A

    1. You have access
      In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
      N Chauret, C Li, Y Ducharme, L A Trimble, J A Yergey, C Ramachandran and D A Nicoll-Griffith
      Drug Metabolism and Disposition January 1995, 23 (1) 65-71;
  7. Tsuruda, L S

    1. You have access
      Metabolism of [14C]naphthalene in the B6C3F1 murine isolated perfused liver.
      L S Tsuruda, M W Lamé and A D Jones
      Drug Metabolism and Disposition January 1995, 23 (1) 129-136;

V

  1. Van Leengoed, L A

    1. You have access
      Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.
      M Monshouwer, R F Witkamp, S M Nijmeijer, L A Van Leengoed, J H Verheijden and A S Van Miert
      Drug Metabolism and Disposition January 1995, 23 (1) 44-47;
  2. Van Miert, A S

    1. You have access
      Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.
      M Monshouwer, R F Witkamp, S M Nijmeijer, L A Van Leengoed, J H Verheijden and A S Van Miert
      Drug Metabolism and Disposition January 1995, 23 (1) 44-47;
  3. Verheijden, J H

    1. You have access
      Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.
      M Monshouwer, R F Witkamp, S M Nijmeijer, L A Van Leengoed, J H Verheijden and A S Van Miert
      Drug Metabolism and Disposition January 1995, 23 (1) 44-47;
  4. Villa, P

    1. You have access
      Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
      A Magistrelli, P Villa, E Benfenati, E J Modest, M Salmona and M T Tacconi
      Drug Metabolism and Disposition January 1995, 23 (1) 113-118;
  5. Völkel, H

    1. You have access
      Nicotine and cotinine accumulation in pigmented and unpigmented rat hair.
      B Gerstenberg, G Schepers, P Voncken and H Völkel
      Drug Metabolism and Disposition January 1995, 23 (1) 143-148;
  6. Voncken, P

    1. You have access
      Nicotine and cotinine accumulation in pigmented and unpigmented rat hair.
      B Gerstenberg, G Schepers, P Voncken and H Völkel
      Drug Metabolism and Disposition January 1995, 23 (1) 143-148;

W

  1. Waidelich, D

    1. You have access
      Biotransformation of CI-937 in primary cultures of rat hepatocytes. Formation of glutathione conjugates.
      U Renner, J Blanz, S Freund, D Waidelich, G Ehninger and K P Zeller
      Drug Metabolism and Disposition January 1995, 23 (1) 94-101;
  2. Wang, R W

    1. You have access
      Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
      D J Newton, R W Wang and A Y Lu
      Drug Metabolism and Disposition January 1995, 23 (1) 154-158;
  3. Wang, Y

    1. You have access
      Isoflurane-chlorodifluoroethene interaction in human liver microsomes. Role of cytochrome P4502B6 in potentiation of haloethene metabolism.
      M T Baker, M J Olson, Y Wang, W C Ronnenberg, J T Johnson and A N Brady
      Drug Metabolism and Disposition January 1995, 23 (1) 60-64;
  4. Witkamp, R F

    1. You have access
      Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.
      M Monshouwer, R F Witkamp, S M Nijmeijer, L A Van Leengoed, J H Verheijden and A S Van Miert
      Drug Metabolism and Disposition January 1995, 23 (1) 44-47;

Y

  1. Yergey, J A

    1. You have access
      In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
      N Chauret, C Li, Y Ducharme, L A Trimble, J A Yergey, C Ramachandran and D A Nicoll-Griffith
      Drug Metabolism and Disposition January 1995, 23 (1) 65-71;
  2. Yukawa, T

    1. You have access
      Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
      K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
      Drug Metabolism and Disposition January 1995, 23 (1) 35-43;

Z

  1. Zeller, K P

    1. You have access
      Biotransformation of CI-937 in primary cultures of rat hepatocytes. Formation of glutathione conjugates.
      U Renner, J Blanz, S Freund, D Waidelich, G Ehninger and K P Zeller
      Drug Metabolism and Disposition January 1995, 23 (1) 94-101;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 23, Issue 1
1 Jan 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics